AI and access to healthcare
Explore how AI and digital services can change access to care and the patient experience.
Healthcare AI · Patient access · Future of care
Healthcare entrepreneur, author and keynote speaker
Bring your audience a clear view of how AI and emerging technology are changing where, when and how people receive care.

Audience fit
Healthcare executives, industry associations, innovators and audiences exploring AI and care delivery.
Match the session to the decisions your audience faces: evaluating an emerging technology, preparing for care outside traditional settings or understanding AI’s implications for their work.
Speaking topics
Explore how AI and digital services can change access to care and the patient experience.
Understand the distinction between AI that produces an answer and AI that takes action, and what that means for leaders.
Examine remote monitoring, connected devices and emerging delivery models that bring healthcare closer to patients.
These themes summarize Robin’s published keynote topics. Final content and audience takeaways are tailored with Robin during event planning.
About Robin
Robin Farmanfarmaian is a healthcare entrepreneur, author and keynote speaker. Her work connects emerging technology with the practical decisions facing healthcare leaders. She has delivered more than 250 keynotes in 16 countries and written four books, including The Patient as CEO and How AI Can Democratize Healthcare. Her sessions translate changes in AI, connected care and patient access for technical and general audiences.
Plan the session
Keynotes, typically 45 to 60 minutes, with content and timing tailored to the audience and event goals. Other formats can be discussed during planning.
Watch Robin
Speaker reel covering AI, healthcare and future trends.
Share your audience, timing and the questions you want the session to address. We will discuss fit and confirm availability.
Discuss your eventPrepared from Robin’s official biography and keynote descriptions, with the speaker reel supplied for this profile.
A DR GPT™ Labs venture